These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20646181)

  • 1. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
    Kennedy S
    J Sex Med; 2010 Oct; 7(10):3449-59. PubMed ID: 20646181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z; Yang D; Yu L; Cui Y
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.
    Kornstein SG; Simon JA; Apfel SC; Yuan J; Barbour KA; Kissling R
    J Womens Health (Larchmt); 2017 Nov; 26(11):1161-1168. PubMed ID: 28817365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.
    Fisher WA; Pyke RE
    Sex Med Rev; 2017 Oct; 5(4):445-460. PubMed ID: 28666836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH
    Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
    Fabre LF; Brown CS; Smith LC; Derogatis LR
    J Sex Med; 2011 May; 8(5):1411-9. PubMed ID: 21324094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA; Kingsberg SA; Shumel B; Hanes V; Garcia M; Sand M
    Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flibanserin for hypoactive sexual desire disorder in premenopausal women.
    Clements JN; Thompson B
    JAAPA; 2018 Jun; 31(6):51-53. PubMed ID: 29846316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vilazodone on sexual function during the treatment of major depressive disorder.
    Clayton AH; Kennedy SH; Edwards JB; Gallipoli S; Reed CR
    J Sex Med; 2013 Oct; 10(10):2465-76. PubMed ID: 23216998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study.
    Clayton AH; Croft HA; Yuan J; Brown L; Kissling R
    J Sex Med; 2018 Jan; 15(1):43-51. PubMed ID: 29289374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 17. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C; Simon JA; Taylor LV; Kimura T; Lesko LM;
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
    Eldon AS; Giraldi A
    Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flibanserin: First Global Approval.
    Deeks ED
    Drugs; 2015 Oct; 75(15):1815-22. PubMed ID: 26412054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of gepirone-ER in the treatment of sexual dysfunction in depressed men.
    Fabre LF; Clayton AH; Smith LC; Goldstein I; Derogatis LR
    J Sex Med; 2012 Mar; 9(3):821-9. PubMed ID: 22240272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.